Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Eukaryotic Gene Expression
IF: 2.156 5-Year IF: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Print: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v20.i2.10
pages 87-103

Tumor Necrosis Factor-α Signaling in Macrophages

Narayanan Parameswaran
Department of Physiology and Division of Pathology, Michigan State University, USA
Sonika Patial
Department of Physiology and Division of Pathology, Michigan State University, USA

ABSTRACT

Tumor necrosis factor-α (TNFα) was cloned over 2 decades ago and its identification in part led to the discovery of a super family of tumor necrosis factors (TNFs) and their receptors. TNFα signals through two transmembrane receptors, TNFR1 and TNFR2, and regulates a number of critical cell functions including cell proliferation, survival, differentiation, and apoptosis. Macrophages are the major producers of TNFα and interestingly are also highly responsive to TNFα. Aberrant TNFα production and TNF receptor signaling have been associated with the pathogenesis of several diseases, including rheumatoid arthritis, Crohn’s disease, atherosclerosis, psoriasis, sepsis, diabetes, and obesity. TNFα has been shown to play a pivotal role in orchestrating the cytokine cascade in many inflammatory diseases and because of this role as a "master-regulator" of inflammatory cytokine production, it has been proposed as a therapeutic target for a number of diseases. Indeed anti-TNFα drugs are now licensed for treating certain inflammatory diseases including rheumatoid arthritis and inflammatory bowel disease. In this review we discuss the discovery of TNFα and its actions especially in regulating macrophage biology. Given its importance in several human diseases, we also briefly discuss the role of anti-TNFα therapeutics in the treatment of inflammatory diseases.


Articles with similar content:

Upside and Downside of Tumor Necrosis Factor Blockers for Treatment of Immune/Inflammatory Diseases
Critical Reviews™ in Immunology, Vol.39, 2019, issue 6
Krishan Kumar Thakur, Bano Shabnam, Varsha Rana, Bidisha Bora, Bharat B. Aggarwal, Kishore Banik, Subhash C. Gupta, Elina Khatoon, Ajaikumar B. Kunnumakkara, Sosmitha Girisa, Bethsebie L. Sailo
Inflammation, NF-κB, and Chronic Diseases: How are They Linked?
Critical Reviews™ in Immunology, Vol.40, 2020, issue 1
Krishan Kumar Thakur, Bano Shabnam, Ruplekha Choudhury, Dey Parama, Henamayee Sahu, Bharat B. Aggarwal, Kishore Banik, Subhash C. Gupta, Ajaikumar B. Kunnumakkara, Sosmitha Girisa, Th. Babita Devi, Bethsebie L. Sailo, Choudhary Harsha
Changes in Adipose Tissue Macrophages and T Cells During Aging
Critical Reviews™ in Immunology, Vol.34, 2014, issue 1
Sanjay K. Garg, Raymond Yung, Hang Shi, Colin Delaney
Gaucher Disease and Malignancy: A Model for Cancer Pathogenesis in an Inborn Error of Metabolism
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 3
Stephan vom Dahl, Pramod K. Mistry, Barry E. Rosenbloom, Tamar Taddei
Immunological Cells and Functions in Gaucher Disease
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 3
Manoj Kumar Pandey, Gregory A. Grabowski